Glynn Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-7,041
| Closed | -$5.49M | – | 45 |
|
|
2025
Q2 | $5.49M | Sell |
7,041
-250
| -3% | -$194K | 1.23% | 17 |
|
|
2025
Q1 | $6.02M | Hold |
7,291
| – | – | 1.58% | 18 |
|
|
2024
Q4 | $5.63M | Hold |
7,291
| – | – | 1.33% | 18 |
|
|
2024
Q3 | $6.46M | Sell |
7,291
-6,199
| -46% | -$5.57M | 1.48% | 16 |
|
|
2024
Q2 | $12.2M | Hold |
13,490
| – | – | 2.47% | 15 |
|
|
2024
Q1 | $10.5M | Hold |
13,490
| – | – | 1.97% | 17 |
|
|
2023
Q4 | $7.86M | Hold |
13,490
| – | – | 1.47% | 20 |
|
|
2023
Q3 | $7.25M | Hold |
13,490
| – | – | 1.57% | 19 |
|
|
2023
Q2 | $6.33M | Hold |
13,490
| – | – | 1.4% | 19 |
|
|
2023
Q1 | $4.63M | Hold |
13,490
| – | – | 1.1% | 20 |
|
|
2022
Q4 | $4.94M | Hold |
13,490
| – | – | 1.2% | 20 |
|
|
2022
Q3 | $4.36M | Hold |
13,490
| – | – | 0.93% | 24 |
|
|
2022
Q2 | $4.37M | Hold |
13,490
| – | – | 0.91% | 26 |
|
|
2022
Q1 | $3.86M | Hold |
13,490
| – | – | 0.52% | 31 |
|
|
2021
Q4 | $3.73M | Hold |
13,490
| – | – | 0.4% | 30 |
|
|
2021
Q3 | $3.12M | Hold |
13,490
| – | – | 0.27% | 30 |
|
|
2021
Q2 | $3.1M | Hold |
13,490
| – | – | 0.28% | 27 |
|
|
2021
Q1 | $2.52M | Hold |
13,490
| – | – | 0.24% | 32 |
|
|
2020
Q4 | $2.28M | Hold |
13,490
| – | – | 0.22% | 31 |
|
|
2020
Q3 | $2M | Hold |
13,490
| – | – | 0.21% | 36 |
|
|
2020
Q2 | $2.21M | Hold |
13,490
| – | – | 0.28% | 31 |
|
|
2020
Q1 | $1.87M | Hold |
13,490
| – | – | 0.35% | 29 |
|
|
2019
Q4 | $1.77M | Hold |
13,490
| – | – | 0.31% | 30 |
|
|
2019
Q3 | $1.51M | Hold |
13,490
| – | – | 0.28% | 31 |
|
|
2019
Q2 | $1.5M | Hold |
13,490
| – | – | 0.26% | 32 |
|
|
2019
Q1 | $1.75M | Hold |
13,490
| – | – | 0.32% | 28 |
|
|
2018
Q4 | $1.56M | Hold |
13,490
| – | – | 0.33% | 26 |
|
|
2018
Q3 | $1.45M | Hold |
13,490
| – | – | 0.29% | 28 |
|
|
2018
Q2 | $1.15M | Hold |
13,490
| – | – | 0.25% | 31 |
|
|
2018
Q1 | $1.04M | Hold |
13,490
| – | – | 0.23% | 34 |
|
|
2017
Q4 | $1.14M | Hold |
13,490
| – | – | 0.24% | 33 |
|
|
2017
Q3 | $1.15M | Hold |
13,490
| – | – | 0.29% | 33 |
|
|
2017
Q2 | $1.11M | Hold |
13,490
| – | – | 0.3% | 32 |
|
|
2017
Q1 | $1.14M | Hold |
13,490
| – | – | 0.34% | 28 |
|
|
2016
Q4 | $992K | Buy |
13,490
+5,610
| +71% | +$418K | 0.34% | 30 |
|
|
2016
Q3 | $632K | Hold |
7,880
| – | – | 0.2% | 38 |
|
|
2016
Q2 | $621K | Sell |
7,880
-2,000
| -20% | -$151K | 0.2% | 42 |
|
|
2016
Q1 | $711K | Buy |
+9,880
| New | +$748K | 0.23% | 44 |
|
Other funds holding LLY
Glynn Capital Management's LLY Position: Q3 2025 in Review
Glynn Capital Management sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 7,041 shares — an estimated $5.49M sold.
Glynn Capital Management first reported a position in LLY in Q1 2016 and held it in 38 quarters. The position peaked at $12.2M in Q2 2024. 3,898 funds tracked by Wall St. Rank hold LLY as of Q3 2025.
- Glynn Capital Management reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
- Glynn Capital Management sold 7,041 Eli Lilly shares in Q3 2025, an estimated $5.49M.
- Glynn Capital Management first reported a position in Eli Lilly in Q1 2016 and held it in 38 quarters.
- Glynn Capital Management's Eli Lilly position peaked at $12.2M in Q2 2024.
- 3,898 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.
Based on Glynn Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.